Reconstitution of Protein Translation of Mycobacterium Reveals Functional Conservation and Divergence with the Gram-Negative Bacterium Escherichia coli

Protein translation is essential for all bacteria pathogens. It has also been a major focus of structural and functional studies and an important target of antibiotics. Here we report our attempts to biochemically reconstitute mycobacterial protein translation in vitro from purified components. This mycobacterial translation system consists of individually purified recombinant translation factors from Mycobacterium tuberculosis (M. tuberculosis), purified tRNAs and ribosomes from Mycobacterium smegmatis (M. smegmatis), and an aminoacyl-tRNA synthetase (AARS) mixture from the cell-extract of M. smegmatis. We demonstrate that such mycobacterial translation system was efficient in in vitro protein synthesis, and enabled functional comparisons of translational components between the gram-positive Mycobacterium and the gram-negative E. coli. Although mycobacterial translation factors and ribosomes were highly compatible with their E. coli counterparts, M. smegmatis tRNAs were not properly charged by the E. coli AARSs to allow efficient translation of a reporter. In contrast, both E. coli and M. smegmatis tRNAs exhibited similar activity with the semi-purified M. smegmatis AARSs mixture for in vitro translation. We further demonstrated the use of both mycobacterial and E. coli translation systems as comparative in vitro assays for small-molecule antibiotics that target protein translation. While mycobacterial and E. coli translation were both inhibited at the same IC50 by the antibiotic spectinomycin, mycobacterial translation was preferentially inhibited by the antibiotic tetracycline, suggesting that there may be structural differences at the antibiotic binding sites between the ribosomes of Mycobacterium and E. coli. Our results illustrate an alternative approach for antibiotic discovery and functional studies of protein translation in mycobacteria and possibly other bacterial pathogens.


Results and Discussion
Purification of recombinant M. tuberculosis translation factors expressed in E. coli The overall workflow for the reconstitution of mycobacterial protein translation is illustrated in Fig 1. The genes for the M. tuberculosis translation factors (Tables 1 and 2) were de novo synthesized and codon-optimized for expression in E. coli, and the recombinant proteins were histidine-tagged for rapid purification on nickel-affinity chromatography. The initiation factors (IF1, IF2), elongation factor G (G, from the fusA1 gene), release factors (RF1, RF2) and ribosome-recycling factor (RRF) were over-expressed as highly soluble proteins and purified to near homogeneity after the nickel column as indicated by the SDS-PAGE analysis (S1A Fig). The over-expressed initiation factor 3 (IF3) was insoluble, found exclusively in inclusion bodies (IB), and was purified under the denaturation condition followed by in vitro renaturation (S1B Fig). The elongation factor Ts (Ts) was expressed as partially soluble protein and a large portion of the expressed protein remained in the pellet (S1C Fig). The soluble Ts was subsequently purified from the nickel column. The elongation factor Tu (Tu) when over-expressed alone was completely insoluble, and therefore was purified from inclusion bodies (IB) and renatured in vitro (S1D Fig). Alternatively, we co-expressed both Tu and Ts genes under a single promoter and purified the Tu/Ts complex to near homogeneity under the native condition after several chromatographic steps (S1E Fig). This Tu/Ts complex was used for the reconstitution of the complete mycobacterial translation system, while the separately purified Tu and Ts were used for the functional conservation experiments in which they were substituted for the E. coli Tu and Ts.
Purification of ribosomes, tRNAs and aminoacyl-tRNA synthetases from M. smegmatis Since M. smegmatis is a non-infectious close relative of M. tuberculosis, we grow M. smegmatis cells as the source for ribosomes, tRNAs and aminoacyl-tRNA synthethases (AARSs) (Fig 1).
In Mycobacterium, AspRS charges both tRNA asp and tRNA asn to yield Asp-tRNA asp and Asp-tRNA asn , respectively. The mis-charged Asp-tRNA asn is immediately converted by M. smegmatis amidotransferase (a complex of three-gene product gatCAB) to Asn-tRNA asn . The similar process also occurs to make Glu-tRNA glu and Gln-tRNA gln . Based on high sequence homologies between the translational components of these two closely related species, we expected M. smegmatis ribosomes and tRNAs to be functionally compatible with M. tuberculosis translation factors. M. smegmatis ribosomes were purified from the cell extract via ultracentrifugation and the ribosomal proteins were analyzed on a SDS-PAGE gel (S2A Fig). Compared to their E. coli counterparts, M. smegmatis ribosomal proteins exhibited somewhat different band patterns and notably lacked the S1 protein, suggesting that S1 was dissociated from the intact M. smegmatis ribosome during purification. The function of purified M. smegmatis ribosomes was examined by substituting E. coli ribosomes in a reconstituted E. coli system to synthesize a reporter. The reconstituted E. coli system did not generate any reporter activity in the absence of ribosomes, but produced~36% of the reporter activity with M. smegmatis ribosomes as compared to E. coli ribosomes (S2B Fig). The data indicate that purified M. smegmatis ribosomes (in spite of the lack of S1) were active in in vitro protein synthesis. The cell extract of M. smegmatis cells was used for isolation of total tRNAs and enrichment of AARSs (Fig 1). Total tRNAs were purified by phenol extraction and isopropanol fractionation and shown to be comparable to the purified total E. coli tRNAs (S3A Fig). We expected all M. smegmatis AARSs to be soluble in the cell extract and they could be enriched by ion exchange chromatography. We collected and pooled the peak fractions from the elution of the DEAE-ion exchange column (S3B Fig (Table 2), which on its own apparently contained sufficient aminoacyl tRNA synthetases, but not other factors to support in vitro synthesis. This is consistent with early studies of in vitro protein synthesis with the E. coli cell extract which was normally used in excess of 10 mg/ml [13].

Reconstitution of mycobacterial protein translation from purified components for efficient in vitro protein synthesis
For in vitro protein synthesis from a DNA template, we used T7 RNA polymerase to couple the transcription from a T7 promoter to in vitro translation. We reconstituted mycobacterial protein translation by mixing purified translation factors, ribosomes, tRNAs and the AARS mixture following similar protocols as described previously for the reconstituted E. coli and Thermus thermophilus translation systems [9,14]. The final concentrations of the components in the mycobacterial translation system are listed in Table 2 and are largely similar to those of the reconstituted E. coli translation system with some modifications. For instance, we used a higher concentration of mycobacterial tRNAs (3 mg/ml) compared to the E. coli translation system (2 mg/ml). The mycobacterial AARSs was a mixture of native enzymes enriched from the M. smegmatis cell extract in contrast to the E. coli translation system in which AARSs consist of 20 individually purified recombinant proteins. We used the purified Tu/Ts complex instead of separate proteins to achieve the highest in vitro synthesis activity in the mycobacterial translation system.
The reconstituted mycobacterial translation system was tested for its ability to synthesize a reporter from a DNA template. We found that the protein synthesis yield was~19% of that of the reconstituted E. coli system (Fig 2, third column). The lower synthesis yield of the mycobacterial translation system could be due to the inherent slow translation by mycobacterial ribosomes, as M. smegmatis grows almost 10 times slower than E. coli. Another possibility was the non-optimal concentrations of M. smegmatis AARSs for more efficient in vitro translation. The M. smegmatis AARSs were purified as a mixture from the cell extract. This precludes the possibility of adjusting the concentration of each M. smegmatis AARS for maximal in vitro protein synthesis as it was the case for the AARSs in the E. coli translation system. We also cannot exclude the possibility that certain components that contribute to efficient protein translation were missing, less active or present at low concentrations in the mycobacterial translation system. To fully reconstitute mycobacterial protein translation, it will be necessary to individually purify all mycobacterial tRNA synthetases as recombinant proteins, including aspartyl/glutamyl tRNA Asn/Gln amidotransferases (products of gatCAB genes) involved in the generation of Asn-tRNA asn and Gln-tRNA gln (Table 1) [15,16].

Functional comparison of the translational components between
Mycobacterium and E. coli The availability of both mycobacterial and E. coli translation systems allowed us to perform the functional comparison of major translational components between gram-positive and gramnegative bacteria. First, we compared M. smegmatis ribosomes with E. coli ribosomes in the reconstituted translation systems for in vitro synthesis of a reporter. When substituting for E. coli ribosomes, M. smegmatis ribosomes in the E. coli translation system resulted in 34% of the reporter activity compared to the complete E. coli translation system, suggesting that M. smegmatis ribosomes are generally compatible with the translation components of E. coli (Fig 2, compare the fourth column to the first column). These data are consistent with similar studies that used Bacillus and M. smegmatis ribosomes in a reconstituted E. coli translation system [6,17]. In comparison, when substituting for M. smegmatis ribosomes, E. coli ribosomes in the mycobacterial translation system resulted in only 15% of the synthesis activity compared to that of the complete E. coli translation system (Fig 2, compare the second column to the first column). At first glance, it seemed that E. coli ribosomes were not very compatible with the mycobacterial translation components. However, compared to the complete mycobacterial translation system, E. coli ribosomes in the mycobacterial translation system resulted in~76% activity (Fig 2, compare the second column to the third column), suggesting that E. coli ribosomes were actually compatible with mycobacterial translation components. Next we investigated the compatibility of the translation factors, AARSs and tRNAs between Mycobacterium and E. coli in the context of the mycobacterial translation (with M. smegmatis ribosomes). A comparison of the amino acid sequence homology between mycobacterial and E. coli translational components reveals varying degrees of the sequence identity (Table 1). Thus it was interesting to investigate how the sequence identity corresponds to the functional compatibility. First, we substituted mycobacterial translation factors (TFs) with their E. coli counterparts in the mycobacterial translation system and analyzed the effect of each substitution on the activity of the translated reporter (S5-S7 Figs). Use of the E. coli initiation factors (IFs) in the mycobacterial translation system decreased in vitro synthesis of the reporter by a factor of 50% compared to the mycobacterial initiation factors (S5 Fig). On the other hand, E. coli elongation factors (Tu and Ts) increased in vitro synthesis of the reporter compared to their mycobacterial counterparts (S6 Fig, compare first and second columns). However, Tu and Ts from mixed species reduced the amount of the synthesized reporter (S6 Fig, compare third and fourth columns), suggesting Tu from one species was not very compatible with Ts from another species. Similar hybrid experiments were performed with the ribosome release factor (RRF) and elongation factor G (EF-G). However, in this case, no significant differences were observed whether these factors were from the same species or mixed species (S7 Fig). Our findings in general suggest that E. coli translation factors can substitute for their mycobacterial counterparts in the mycobacterial system without significantly affecting in vitro synthesis of the reporter. This functional conservation of translation factors between Mycobacterium and E. coli is consistent with a previous study that used a similar in vitro biochemical approach [12]. Though major translational components from Mycobacterium and E. coli were purified under similar conditions and used in the same concentrations in these comparative studies, we cannot exclude the possibility that one or a few mycobacterial components were less active and led to the differences we observed in the results described above.
The most striking differences were observed when E. coli AARSs and/or tRNAs replaced their mycobacterial counterparts in the mycobacterial translation system (Fig 3). M. smegmatis AARSs seemed to be able to charge E. coli tRNAs at a similar efficiency as M. smegmatis tRNAs, as judged by the similar reporter activities (albeit~30% more for E. coli tRNAs) (Fig 3, first and second columns). In contrast, E. coli AARSs resulted in almost a complete loss in the reporter activity with M. smegmatis tRNAs (Fig 3, third column). Such drastic decrease in the reporter activity did not seem to be caused by the use of E. coli translation factors (TFs) (Fig 3, third column) since E. coli TFs were generally compatible with the rest of the mycobacterial translation components (S5-S7 Figs). These data suggest that E. coli AARSs appeared to be incapable of properly recognizing M. smegmatis tRNAs, possibly resulting in uncharged or mis-charged tRNAs and the loss of the reporter activity. This incompatibility could be due to the sequence (e.g., N73) and modification differences between M. smegmatis and E. coli tRNAs in general, and non-discriminating M. smegmatis aminoacyl tRNA synthetases and their tRNAs in particular. For instance, M. smegmatis tRNA asp and tRNA asn were both charged by the same M. smegmatis non-discriminating aspartyl-tRNA sythetases (ND-AspRS) to yield Asp-tRNA asp and Asp-tRNA asn , respectively. The mis-charged Asp-tRNA asn is immediately converted by M. smegmatis amidotransferase to Asn-tRNA asn . The similar process also occurs in M. smegmatis to make Glu-tRNA glu and Gln-tRNA gln . In contrast, E. coli AARSs consist of 20 individually purified synthetases, none of which is a non-discriminating synthetase. E. coli tRNA asn and tRNA gln are charged by the specific (discriminating) aspariginyl-tRNA and glutaminyl-tRNA synthetases, respectively. The lack of amidotransferases in E. coli and the possibility of E. coli AARSs not being able to properly charge M. smegmatis tRNAs due to the sequence differences may account for the above observation (Fig 3, column 3).
Though a number of M. smegmatis AARSs have very low amino acid sequence identities with those of E. coli AARSs (Table 1, e.g., Ile-and Met-tRNA synthetases at 26%), as far as the synthesis of the active reporter is concern, M. smegmatis AARSs seemed to be able to properly charge E. coli tRNAs (Fig 3, second column). The reason for this observation was not clear. M. smegmatis AARSs in these experiments lacked Asn-and Gln-tRNA synthetases, and contained essentially most soluble proteins from the M. smegmatis extract. M. smegmatis relies on a twostep mechanism and amidotransferases to generate M. smegmatis Asn-tRNA Asn and Gln-tRNA Gln . Whether this process occurred with E. coli tRNAs in the mycobacterial translation system remains to be tested. Future experiments will individually purify recombinant M. smegmatis AARSs including amidotransferases, which would allow us to address the above questions and at the same time fully reconstitute the mycobacterial protein translation.
Use of both mycobacterial and E. coli translation systems as a comparative in vitro assay platform for testing antibiotics that specifically target M. tuberculosis protein translation Structural studies of antibiotics-bound ribosomes have provides insights on the mechanisms of translation inhibition by antibiotics. However, these studies are often limited to the model organisms such as E. coli and Thermus thermophilus [18,19]. To date, there is no high-resolution crystal structure of the ribosome from any pathogenic bacterium, hindering the rational design of antibiotics that specifically target the pathogenic bacterium. The structural differences of the mycobacterial ribosome from the E. coli ribosome revealed by the cryo EM studies [5] suggest a possibility of screening small molecules that preferentially target the mycobacterial translation.
Since it consists of only ribosomes and other translational components, a totally reconstituted bacterial protein synthesis system could be an ideal platform to assay and screen smallmolecules that target the translation process. With the availability of both mycobacterial and E. coli translation systems, small molecules that target mycobacterial translation more specifically than that of E. coli or vice versa could be readily identified. To demonstrate such feasibility, we tested two known antibiotics, spectinomycin and tetracycline. We examined the inhibitory effects of the antibiotics by measuring the activity of the reporter synthesized in either mycobacterial or E. coli translation system in the presence of different concentrations of the antibiotics. We found that spectinomycin inhibited both mycobacterial and E. coli translation with a similar in vitro efficacy (IC 50 at~1 μg/ml) (Fig 4). In contrast, tetracycline preferentially inhibited mycobacterial translation with the estimated IC 50 at~2 μg/ml, while the IC 50 for E. coli translation was~40 μg/ml (Fig 4). Based on co-crystal structures with the ribosomes from E. coli or Thermus thermophilus, both antibiotics inhibit protein translation by binding to the 30S ribosomal subunit [20][21][22]. Spectinomycin interacts with the head domain of the 30S subunit and block translocation of mRNA and tRNAs on the ribosome [21]. On the other hand, tetracycline interferes with aminoacyl-tRNA entrance by binding to the A site of the ribosome [22]. Our data point to a possibility that there may be structural differences at the ribosomal A site between M. smegmatis and E. coli that allow tetracycline to inhibit the M. smegmatis ribosomes at much lower concentrations. However, we cannot rule out the possibility of other mechanisms of action. For instance, E. coli ribosomes may contain some species-specific ribosome-associated proteins that interfere with the tetracycline binding. Tetracycline may preferentially interact with other translational components in the mycobacterial translation system and inhibit protein translation through yet-to-identified mechanisms. We additionally tested the effects of chloramphenicol, which prevents translation elongation by inhibiting peptidyl transferase activity of ribosomes (S8 Fig). Both mycobacterial and E. coli translation were inhibited by chloramphenicol with relatively similar in vitro efficacies (IC 50 at~5 and 1 μg/ml, respectively) (S8 Fig). We have previously demonstrated the use of the E. coli translation system for screening small molecule inhibitors in 1536-well plates [10], mycobacterial translation system in this study should be amenable to microplate-based high throughput assays. The total number of assays will be determined by the amount of mycobacterial translation system one can produce at reasonable costs. Most of the components of mycobacterial translation systems can be produced in fairly large amounts with small-scale cell cultures. The most limiting component is M. smegmatis tRNAs, which we purified~31 mg from 25 g cells, corresponding to 400 reactions (25 μl per reaction). Therefore, mycobacterial translation system at the current scale may be suitable for screening small molecules from targeted libraries.

Conclusions
This work illustrates a bottom-up biochemical approach for functional studies of the protein translation machinery of mycobacteria and possible other bacterial pathogens. We have established the feasibility that protein translation systems derived from different bacteria may be used to identify species-specific antibiotics. Our goal has been to construct a translation system consisting of the translational components entirely from an infectious M. tuberculosis strain. However, the current mycobacterial translation system is still a hybrid system in which AARS, tRNAs and ribosomes are purified from Mycobacterium smegmatis, an easy-to-grow close relative of M. tuberculosis. To achieve a complete biochemical reconstitution of protein translation as well as transcription regulation of an infectious M. tuberculosis strain, the future works would involve purification of recombinant M. tuberculosis AARSs, recombinant amidotransferases, RNA polymerase holoenzyme and transcription factors, and isolation of ribosomes and tRNAs from M. tuberculosis cells. Such a complete M. tuberculosis cell-free system may be used as an "in vitro genetic tool" [8,10] for functional studies of M. tuberculosis-specific genes and pathways and for screening M. tuberculosis-specific antibiotics.

Materials and Methods Reagents
Unless specified otherwise, the chemicals were purchased from Sigma-Aldrich (St. Louis, MO), the reagents including the reconstituted E. coli translation system (derived from PURExpress™) were from New England Biolabs (NEB) (Ipswich, MA), and the primers were ordered from Integrated DNA Technologies (Coralville, IA).

Cloning, expression and purification of recombinant M. tuberculosis translation factors from E. coli
The genes encoding IF1, IF2, IF3, RF1, RF2, RRF, EF-Tu, EF-Ts, EF-G were synthesized by GeneScript (Piscataway, NJ) with codons optimized for expression in E. coli. All genes were cloned into the expression vector, pCOATexp, derived from pTYB1 vector (New England Biolabs), to allow expression of recombinant proteins with a C-terminal histidine-tag. The expression vectors were transformed into E. coli strains ER3095 (New England Biolabs).
For each histidine-tagged protein, cells transformed with the expression vector were grown at 37°C to OD600 of 0.6 in 2-6 L Luria-Bertani (LB) broth. Isopropyl-β-D-thiogalactoside (IPTG) was then added to a final concentration of 0.1 mM and the cells were grown for an additional 4-5 hr at 37°C. Cells were harvested by centrifugation and lysed by sonication in lysis buffer (50 mM Tris-HCl, pH7.5, 300 mM KCl, 10 mM MgCl2, 20 mM imidazole, and 1 mM β-mercaptoethanol). Cell debris was removed by centrifugation at 16,000 g for 1 hr at 4°C and the supernatant was applied to a 10 ml HisTrap FF column (GE healthcare, Piscataway, NJ). After washing the column with 100 ml lysis buffer, the his-tagged protein was eluted with a linear gradient of 20 mM to 250 mM imidazole in lysis buffer. Fractions containing the histagged protein were combined and dialyzed against the storage buffer (25 mM Tris-HCl, pH7.5, 100 mM K-glutamate, 10 mM Mg(OAc)2, 30% glycerol, and 1 mM β-mercaptoethanol) and stored frozen in small aliquots at -80°C.
In the case of IF3 and EF-Tu, both recombinant proteins were insoluble and mostly found in the fractions of the inclusion bodies (IB) (S1B and S1D Fig). To solubilize the inclusion bodies, cell pellet after centrifugation was washed twice with a washing buffer (20 mM Tris, pH7.5, 10 mM EDTA and 1% Triton X-100) and then dissolved in a denaturation buffer (20 mM Tris, pH8.5, 4M urea). After centrifugation at 16,000 g for 30 min at 4°C to remove undissolved materials, the supernatant was applied to a 10 ml HisTrap FF column (GE healthcare, Piscataway, NJ) equilibrated with the renaturation buffer 1 (20 mM Tris, pH8.5, 2M urea). After washing the column with the renaturation buffer 1, IF3 or EF-Tu was eluted with a linear gradient of 10 mM to 200 mM imidazole in the renaturation buffer 1. Fractions containing the IF3 or EF-Tu protein were combined and dialyzed against the renaturation buffer 2 (20 mM Tris, pH8.5, 1M urea) and then the renaturation buffer 3 (20 mM Tris, pH8.5). The solubilized proteins were stored frozen in small aliquots at -80°C M. tuberculosis EF-Tu was also purified as a complex with M. tuberculosis EF-Ts. In this case, the genes for M. tuberculosis EF-Ts and EF-Tu were cloned into the MCS1 and MCS2 of pETDuet-1 respectively. A peptide MGSSHHHHHHSQDPNS was engineered to the N-terminus of EF-Ts to add a 6xHis-tag and a linker region to facilitate the affinity purification of the EF-Tu/Ts complex. The plasmid was transformed into Rosetta DE3 competent cells. The cells were grown at 37°C to OD 600 = 1.0 and then induced by adding IPTG to a final concentration of 0.5mM. The induction was continued at 25°C overnight with shaking. Cells were harvested by centrifugation at 3,000 rpm for 20 mins. The cell pellet was re-suspended in the Lysis buffer containing 50 mM of Tris pH 8.0, 150 mM of NaCl and 10mM of Imidazole. Cells were disrupted by ultrasonication on ice, followed by centrifugation at 15,000rpm for 30mins at 4°C to remove the cell debris. The supernatant was loaded to a 3ml Ni-NTA(Qiagen) pre-equilibrated with the Lysis buffer. The resin was washed with 20 column volumes Lysis buffer and then eluted with the elution buffer containing 50 mM Tris 8.0, 150 mM NaCl and 100 mM Imidazol. The eluate was immediately dialyzed against a buffer containing 50mM of Tris pH 8.0 and 150mM of NaCl. The sample was loaded to a 5-ml anion exchange column Hitrap Q HP (GE healthcare) and eluted with a linear gradient of 150 mM to 1M NaCl. Two peaks from the ion exchange chromatography were observed, both of which contain protein species corresponding to the molecule weights of EF-Tu and EF-Ts. Mass spectrometry analysis was performed to identify that the first peak contained the complex of of E. coli EF-Tu and M. tuberculosis EF-Ts, whereas the second peak contained the complex of M. tuberculosis EF-Tu and M. tuberculosis EF-Ts. Therefore, the second peak was collected and subjected to a size-exclusion column Superose 6 10/300 GL (GE healthcare). The eluate containing the M. tuberculosis EF-Tu/Ts complex was pooled and concentrated to~30 mg/ml. The protein concentrations were determined by Bradford Assay. For SDS-PAGE analyses, aliquots were taken from the in vitro translation reactions and run on a 10-20% Tris-glycine SDS-PAGE gels (Life Technologies, Carlsbad, CA).
Purification of M. smegmatis ribosomes and testing the protein synthesis activity M. smegmatis ribosomes were purified using established protocols with minor modification [9,23]. All buffers and purification procedures were at 4°C, unless otherwise noted. Specifically, M. smegmatis(ATCC 19420) cells were grown in small-scale fermentation (10 L) in NEB fermentation facility. The culture was cooled rapidly and the cells were harvested by centrifugation. Fresh cell paste (80 g) was washed twice in 200 ml of wash/lysis buffer (20 mM Tris-HCl, pH7.5, 100 mM NH4Cl, 10.5 mM MgCl2, 0.5 mM EDTA, 6 mM β-mercaptoethanol) and then resuspended in 150 ml of the same wash/lysis buffer. The cells were disrupted at 40 kpsi by a cell disruption system (Constant Systems, Low March, Daventry, Northants, United Kingdom) and cell debris was removed by centrifugation at 30,000 g for 1 hr. The supernatant was centrifuged again at 30,000 g for additional 30 min and saved as the M. smegmatis S30 extract. For ribosome purification, 25 ml of the S30 extract was overlayered onto 13 ml of a sucrose cushion (Cushion I: 20 mM Tris-HCl, pH7.5, 10.5 mM MgCl2, 0.5 mM EDTA, 1.1 M Sucrose, 6 mM βmercaptoethanol, 2mM DTT) in each ultracentrifuge tube, and the ultracentrifugation was conducted in a Beckman SW28 rotor at 28,000 rpm for 22 hr. The pellet containing the ribosome was solubilized in the ribosome storage buffer (25 mM Tris-OAc, pH7.5, 100 mM NH4OAc, 10 mM Mg(OAc)2, 6 mM β-mercaptoethanol, 2mM DTT) by overnight incubation at 4°C. The purified ribosome was concentrated to an appropriate concentration and stored frozen in aliquots at -80°C. The final concentration of the purified ribosome was measured at A260. Aliquots of the purified M. smegmatis and E. coli ribosomes were loaded on a SDS-PAGE gel for comparison and purity check (S2A Fig). The activity of the purified M. smegmatis ribosomes was tested for in vitro synthesis of a reporter in a reconstituted E. coli system in which E. coli ribosomes were removed. The protein synthesis reactions (25μl) were set up by mixing the reconstituted protein synthesis system containing 2.4μM either E. coli or M. smegmatis ribosomes with RNase inhibitor (2 units) and 200 ng reporter DNA templates (pUCAT7Fluc) expressing the firefly luciferase (Fluc) under a T7 promoter. The reaction mixtures were incubated at 37°C for 4 hr and aliquots were taken for luciferase assays.
Purification of total M. smegmatis tRNAs and enrichment of M. smegmatis AARSs from the M. smegmatis cell extract 1. Purification of total M. smegmatis tRNAs. M. smegmatis cells were lysed as described above in the ribosome purification protocol. The lysate was clarified by low speed centrifugation (10000 rpm for 20 minutes) in a Sorvall centrifuge. Clarified lysate was divided in equal halves and one half was used for total tRNAs preparation whereas the another half was used for AARSs enrichment (see below). Briefly, The clarified cell lysate was passed through a DEAE column equilibrated with 50 mM Tris-HCl, pH7.5, 0.5 mM EDTA, 6 mM β-mercaptoethanol, 50mM NaCl. Fractions were eluted with a linear gradient of 100 mM to 1500mM NaCl in the aforesaid equilibrium buffer. All the fractions exhibiting UV absorbance (representing either soluble proteins, nucleic acids or a mix of both) were pooled and diluted with the aforesaid equilibrium buffer and mixed with an equal volume of the saturated phenol solution (pH 6.6) and incubated at 37°C for 30 min. After centrifugation at 13,000 g for 15 min, the upper layer was collected and subject to a second phenol extraction and centrifugation step. The nucleic acids (DNA and RNA) in the upper layer were then precipitated by adding 0.1 volume of 3M sodium acetate (pH5.3) and 2.5 volume of cold ethanol, and incubating overnight at -20°C. Following centrifugation at 13,000 g for 30 min, the pellet was dried and then dissolved in 70 ml of 0.3 M sodium acetate (pH7.0). To precipitate DNA and high molecular weight RNA, isopropanol (38 ml) was added slowly in drops with a needle at 4°C. After centrifugation at 13,000 g for 30 min, the supernatant (~108 ml) was collected and mixed with 31 ml of isopropanol. Following centrifugation at 13,000 g for 30 min, pellet of the precipitated tRNAs was dried and dissolved in H2O. The final concentration of total tRNA was measured at A260.
2. Enrichment of M. smegmatis AARSs from the cell lysate. We applied the clarified lysate on a DEAE-cellulose column equilibrated with 50 mM Tris-HCl, pH7.5, 0.5 mM EDTA, 6 mM β-mercaptoethanol followed by elution against a linear gradient of 0.0-0.5M NaCl in the same buffer. The protein fractions were pooled and precipitated with 100% ammonium sulfate. The precipitate was recovered by low speed centrifugation (15,000g for 30 minutes), dissolved in a buffer containing 50 mM Tris-HCl, pH7.5, 0.5 mM EDTA, 6 mM β-mercaptoethanol, 20 mM NaCL and dialyzed twice against the same buffer. The resulting preparation enriched in mycobacterial AARSs was used for the reconstitution of mycobacterial protein translation.

Reconstitution of mycobacterial protein translation from purified components
Following a protocol similar to that of the reconstituted E. coli translation system, the mycobacterial translation was reconstituted by mixing the purified M. tuberculosis translation factors, M. smegmatis AARSs mixture, M. smegmatis tRNAs and ribosomes, E. coli energy regeneration enzymes, T7 RNA polymerase (for coupling transcription to translation), and small molecules (see Table 2 for the complete list and concentrations). The protein synthesis reactions (typically 25μl each reaction) were set up by mixing the reconstituted protein synthesis system with RNase inhibitor (2 units) and 200 ng reporter DNA templates (pUCAT7Fluc) expressing the firefly luciferase (Fluc) under a T7 promoter. The reaction mixtures were incubated at 37°C for 4 hr and aliquots were taken for the luciferase assays.

Functional comparison of the translational components between Mycobacterium and E. coli
The experiments swapping the mycobacterial and E. coli translation components (translation factors (TFs, individually or all together), AARSs, tRNAs, ribosomes) were primarily conducted in in vitro translation reactions that synthesized the Fluc reporter (Figs 2 and 3 and S2-S7 Figs). The mycobacterial translation components were either removed or replaced by equal amounts of corresponding E. coli counterparts.

In vitro antibiotic inhibition assays in mycobacterial and E. coli translation systems
The assays (25μl each assay) were set up by mixing the mycobacterial or E. coli translation system with RNase inhibitor (2 units), 200 ng reporter DNA templates (pUCAT7Fluc) expressing the firefly luciferase (Fluc) and various amounts of spectinomycin or tetracycline. The reaction mixtures were incubated at 37°C for 4 hr and aliquots were taken for the luciferase assays.

Luciferase activity assay
The activity of the Fluc reporter was assayed using the Luciferase Assay System (Promega, Madison, WI) in a microplate luminometer (Centro LB 640, Berthold Technologies, Oak Ridge, TN) according to manufacturers' instructions. Protein synthesis reactions were diluted 10-fold in 1x cell culture lysis reagent (Promega, Madison, WI) containing 1 mg/ml BSA. Aliquots (5 μl) were added in triplicate to a microplate for the luciferase assay in the luminometer.